Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
212.50    0.00 (0.00%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £145.08m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Capacity Value Update

15 Nov 2024 07:00

RNS Number : 3337M
Helios Underwriting Plc
15 November 2024
 

 

 

15 November 2024

 

Helios Underwriting plc

 ("Helios" or the "Company")

Capacity Value Update

 

Helios Underwriting ('Helios' or the 'Company'), the only publicly traded company offering access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, today announces an update on the value of Company's capacity portfolio following the Capacity Auctions at Lloyd's.

 

Michael Wade, Chairman of Helios, commented:

 

"The Freehold Capacity Portfolio has continued to deliver value to shareholders and we have  realised £14m of capacity value to increase the tangible assets of the Company. An increase in the Net Asset Value per share of 15p (2023 - 18p) to 206p is expected , representing an increase of 8% over the reported NAV as at 30th June 2024, and this demonstrates the strength of our portfolio."

 

Capacity Value

The value of the capacity fund expected as at 31st December 2024 using the weighted average prices of capacity from the 2024 Lloyd's capacity auctions is expected to decrease to £75m (31 December 2023: £82.4m) having realised £14m of cash from some of syndicates within the portfolio.

 

The analysis of the changes to the Freehold Capacity in the portfolio is as follows:

 

Freehold Capacity

Value of Capacity

Value per £ capacity

 

£m

£m

 

Capacity Portfolio at 31 Dec 2023

175.9

82.4

0.47

Pre-emption capacity

15.6

3.4

Mid-year support

5.0

-

Disposal of capacity at capacity auctions

-37.8

-13.9

Increase / Acquisition of Freehold capacity

10.8

0.1

Increase in portfolio value

2.9

Capacity Portfolio expected at 31 Dec 2024

166.4

74.9

0.45

 

A summary of the movements in capacity and its value as follows:

 

The syndicates supported by Helios offered free capacity of £15.6m (2023 - £14.7m) by way of pre-emptions to support the improved underwriting market. The value of the pre-emptions taken up have increased the value of the portfolio by £3.4m (2023 £7.0m).

 

Helios supported the Fidelis Syndicate (syndicate 3123), which commenced business in July 2024 and will allocate £13m of capacity for the 2025 year of account to this syndicate. The weighted average price for this syndicate was 28p per £ of capacity in the recent auctions.

 

The average price per £ of capacity with value after the 2024 Auctions was 45p (2022 - 47p) reflecting a small decrease in auction prices and change in the mix of the freehold portfolio. 

 

Impact on Net Asset Value as 30th June 2024

Total

Net Assets

 

£m

per Share - £

 

Opening at 30th June 2024

140.7

1.91

Pre-emption capacity

3.4

Net profit on disposal of syndicate capacity

1.8

Increase in portfolio value

2.9

8.1

Corporation Tax provision

-2.0

Pro-forma Net Asset Value

146.8

2.06

Number of shares in Issue

71.3

 

 

The sale of £38m of capacity on the auctions resulted in a small profit of £1.8m from the value held on the balance sheet. It has increased both the cash available and the Tangible Net Assets by £14m and has reduced the exposure in the balance sheet to the value of the capacity.

 

Following the 2024 Auctions and taking into account the further buy back of shares by the Company in July, the proforma Net Asset per share as 30th June 2024 is expected to increase by 8% to 206p

 

The Company expects to publish its updated Net Asset Value as at 30 September 2024 per share in early December 2024.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) NO 596/2014.

ENDS

For further information, please contact:

Helios Underwriting plc

Michael Wade - Chairman

Arthur Manners - Chief Financial Officer +44 (0)203 965 6441

Deutsche Numis (Nomad and Broker)

 Giles Rolls / Charles Farquhar

+44 (0)20 7260 1000

 

FTI Consulting

Ed Berry / Tom O'Brien

heliosunderwriting@fticonsulting.com

+44 (0)7703 330 199 / +44 (0)7929 021 492

 About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £512m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDQKQBQOBDDNDD
Date   Source Headline
2nd Feb 20217:00 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSAppointment of Financial Adviser
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSMaterial Capacity Increase
30th Nov 20209:57 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
26th Nov 20203:40 pmRNSResult of GM, TVR and Directors' Participations
24th Nov 20207:00 amRNSResult of Open Offer
19th Nov 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
2nd Nov 20207:00 amRNSPlacing, Subscription, Open Offer & Acquisitions
7th Oct 20207:00 amRNSProposed Fundraising
25th Sep 20207:00 amRNSHalf-year Report
17th Aug 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
10th Aug 20207:00 amRNSUpdate on Capacity and Growth Plans
25th Jun 202012:38 pmRNSResult of AGM
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 202012:28 pmRNSHolding(s) in Company
1st Jun 20207:30 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSFinal results for the year ended 31 December 2019
30th Mar 20207:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20207:00 amRNSCapacity Update and Transaction in Own Shares
13th Dec 20197:00 amRNSAcquisition
18th Nov 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
7th Oct 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20199:39 amRNSReplacement- Transaction in Own Shares
2nd Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20197:00 amRNSTransaction in Own Shares
16th Aug 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
15th Aug 20194:28 pmRNSHolding(s) in Company
12th Aug 20197:00 amRNSProposed Ordinary Share repurchases
19th Jul 20198:47 amRNSHolding(s) in Company
16th Jul 20191:00 pmRNSResult of Meeting
28th Jun 20193:13 pmRNSResult of AGM
13th Jun 20197:00 amRNSChange of Adviser
13th Jun 20197:00 amRNSFundraising, Acquisition, Waiver & Notice of GM
31st May 20197:00 amRNSFinal results for the year ended 31 December 2018
30th May 20192:14 pmRNSDirector's Disclosure
17th May 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
10th May 20199:30 amRNSTrading Update
29th Mar 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20197:00 amRNSDirector Dealing
23rd Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.